Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CAMP vs DGII: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DGII Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

DGII Overall Winner 6-Pillar Tally: CAMP 0 – 6 DGII Matrix Metrics: CAMP 2 – 8 DGII

As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas DGII carries 41.1/100 (SELL) at $53.16 (15.1x Forward P/E, 14.9% operating margin).

  • Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (41.9/100 SELL vs. DGII 41.1/100 SELL), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY).
  • Defensive Composite Rating Caution: Although DGII compares more favorably head-to-head, both CAMP (41.9/100 SELL) and DGII (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile DGII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CAMP vs DGII
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol 1.34β · 94% Vol
Unified Composite Score
41.9 / 100 SELL
Tech 30.0 Fund 40.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.3 · SMA20: $3.82 · SMA50: $3.84
DGII NASDAQ Head-to-Head Winner
Digi International Inc
Computer Communications Equipment
$53.16
+0.42% 1D
Market Cap $2.1B
TTM Revenue $535M
Forward P/E 15.1x
Beta / 30D Vol 1.94β · 78% Vol
Unified Composite Score
41.1 / 100 SELL
Tech 35.0 Fund 40.0 Flow 54.0 Mom 30.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 27
RSI-14: 27.5 · SMA20: $68.39 · SMA50: $71.35

6-Pillar Scorecard Institutional Category Breakdown (CAMP 0 – 6 DGII)

Columns: Metric · CAMP · DGII
1. Valuation Multiples DGII
Forward P/E N/M 15.1x
Trailing P/E N/M 40.2x
PEG Ratio N/M 0.83x
EV / Revenue 26.6x 3.9x
2. Growth & Scale DGII
Revenue Growth (YoY) +138.9% +25.3%
Earnings Growth (YoY) +0.0% +45.6%
TTM Revenue (USD) $5.3M $535M
Market Cap $238.5M $2.1B
3. Profitability & Quality DGII
Gross Margin N/A 63.8%
Operating Margin -991.8% 14.9%
Net Profit Margin 0.0% 10.0%
Return on Equity (ROE) -146.1% 8.0%
4. Balance Sheet & Cash Flow DGII
Cash Generation (TTM) -$26M $125M EBITDA
Cash Flow Margin N/A 23.3% EBITDA Mgn
Net Cash / Leverage $97M Net Cash $18.58 Book/Sh · 8.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DGII
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 50.6% (9th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat DGII
OpEx & R&D Intensity N/A 48.9% of Rev ($262M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Communication Equipment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CAMP (2) vs DGII (8)
Institutional Metric CAMP DGII Criterion Row Edge
Market Capitalization
Scale
$238.5M $2.1B Larger Scale DGII
Trailing P/E Ratio
Valuation
N/M 40.2x Lower Multiple DGII
Forward P/E Ratio
Valuation
N/M 15.1x Lower Multiple DGII
Revenue Growth (YoY)
Growth
+138.9% +25.3% Higher Growth CAMP
Operating Margin (TTM)
Profitability
-991.8% 14.9% Higher Margin DGII
Net Profit Margin
Profitability
0.0% 10.0% Higher Margin DGII
Return on Equity (ROE)
Capital Efficiency
-146.1% 8.0% Higher ROE DGII
52-Week Range Position
Momentum
22% ($3–$8) 33% ($37–$87) Stronger Trend DGII
Beta / 30D Volatility
Risk Regime
1.34β · 94% Vol 1.94β · 78% Vol Lower Realized Risk DGII
Unified Institutional Score
Composite Signal
41.9 / 100 (SELL) 41.1 / 100 (SELL) Higher Composite CAMP
Trailing 12M Revenue (USD)
Operating Scale
$5.3M $535M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 63.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 26.6x EV/Rev 0.83x PEG · 3.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$26M ($97M Net Cash) $125M EBITDA ($18.58 Book/Sh · 8.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CAMP +53.2 pp
CAMP: +25.8% · DGII: -27.4%
3M Horizon CAMP +15.09 pp
CAMP: -15.05% · DGII: -30.14%
6M Horizon CAMP +8.67 pp
CAMP: -4.82% · DGII: -13.49%
1Y Horizon DGII +42.17 pp
CAMP: -3.66% · DGII: +38.51%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CAMP Revenue DGII Revenue CAMP Op. Margin DGII Op. Margin Margin Leader
FY2018 N/A $230M N/A 1.2% DGII
FY2019 N/A $250M N/A 4.0% DGII
FY2020 N/A $280M N/A 4.1% DGII
FY2021 N/A $310M N/A 3.4% DGII
FY2022 N/A $390M N/A 9.8% DGII
FY2023 $0M $440M -14822.6% 11.3% DGII
FY2024 $0M $420M -8142.3% 11.3% DGII
FY2025 $0M $430M -1502.4% 13.1% DGII

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CAMP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DGII CONSOLIDATION
117d in phase · OBV DISTRIBUTION
Current IV 50.6%
IV Percentile 9th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact DGII Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CAMP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
DGII Moat Profile Cyclical / Execution-Driven Positioning
Communication Equipment Operator
Competes within the Communication Equipment value chain with $2.1B market capitalization and 14.9% operating margin.
OpEx & R&D Reinvestment 48.9% of Rev ($262M)
90D Engineering Disclosures 0 Published

Investor FAQ CAMP vs DGII Key Questions & Quantitative Answers

As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas DGII carries 41.1/100 (SELL) at $53.16 (15.1x Forward P/E, 14.9% operating margin). Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (41.9/100 SELL vs. DGII 41.1/100 SELL), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY). Defensive Composite Rating Caution: Although DGII compares more favorably head-to-head, both CAMP (41.9/100 SELL) and DGII (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile DGII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DGII leads the Growth & Scale pillar: CAMP posts +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin), compared with DGII at +25.3% YoY revenue growth and +45.6% YoY earnings growth on $535M TTM revenue (63.8% gross margin, 14.9% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CAMP cumulative revenue shifted N/A while DGII shifted +87.0%. In operating R&D and SG&A reinvestment, CAMP deploys N/A (0 90-day corporate R&D disclosures) versus 48.9% of Rev ($262M) (0 disclosures) for DGII.

DGII screens cheaper on headline valuation multiples. CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin), whereas DGII trades at 15.1x Forward P/E, 40.2x Trailing P/E, 0.83x PEG, and 3.9x EV/Revenue (23.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CAMP (-146.1% ROE) versus DGII (8.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk). By comparison, DGII carries 50.6% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.94β · 78% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.